PRESS RELEASE published on 02/28/2024 at 07:30, 2 years 2 months ago 3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 BRAIN Biotech AG reports optimistic outlook for fiscal year 2023/24 with strong start in BioScience business. Quarterly report includes details on revenue and segment performance Revenue Growth Financial Performance BRAIN Biotech AG Fiscal Year 2023/24 BioScience Business
BRIEF published on 02/28/2024 at 07:30, 2 years 2 months ago BRAIN Biotech AG: Review of the first quarter of the 2023/24 financial year Financial Report Organic Growth BRAIN Biotech AG BioScience BioProducts
PRESS RELEASE published on 09/28/2023 at 10:30, 2 years 7 months ago BRAIN Biotech AG: BRAIN Biotech AG´s Akribion Genomics team wins first prize at the “BioRiver Boost!” startup competition
PRESS RELEASE published on 09/14/2023 at 10:30, 2 years 8 months ago BRAIN Biotech AG: BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®
PRESS RELEASE published on 09/12/2023 at 15:45, 2 years 8 months ago BRAIN Biotech AG: Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family
PRESS RELEASE published on 08/30/2023 at 07:30, 2 years 8 months ago BRAIN Biotech AG reports solid 9M numbers despite ongoing high R&D investments and more challenging economic conditions
PRESS RELEASE published on 06/28/2023 at 13:00, 2 years 10 months ago BRAIN Biotech AG´s Akribion Genomics team successfully competes in Science4Life Venture Cup competition
PRESS RELEASE published on 06/19/2023 at 12:30, 2 years 11 months ago Anniversary of BRAIN Biotech AG: 30 years for a bio-based future
PRESS RELEASE published on 05/25/2023 at 07:30, 3 years ago BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy
PRESS RELEASE published on 05/24/2023 at 09:30, 3 years ago BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy
Published on 05/27/2026 at 22:30, 33 minutes ago Loop Industries Reports Fourth Quarter and Full Year Fiscal 2026 Results and Provides Update on Business Developments
Published on 05/27/2026 at 22:10, 53 minutes ago Organto Foods Announces Appointment of Darryl Bergman as President
Published on 05/27/2026 at 22:01, 1 hour 2 minutes ago Totec Resources Approved for Listing on OTCQB(R) Venture Market
Published on 05/27/2026 at 15:25, 7 hours 38 minutes ago LaFleur Announces Upsize of Bought Deal Equity Offerings for Gross Proceeds of C$10 Million
Published on 05/27/2026 at 15:22, 7 hours 41 minutes ago AmeriTrust Announces First Quarter 2026 Financial Results
Published on 05/27/2026 at 20:52, 2 hours 10 minutes ago EQS-Adhoc: REPLOID Group AG: Procedural deficiencies related to the appointment of auditors in prior periods require remediation. Publication of the 2025 Annual Statements delayed.
Published on 05/27/2026 at 20:32, 2 hours 30 minutes ago Sirma Group Holding AD reports strong profitability growth in Q1 2026
Published on 05/27/2026 at 19:55, 3 hours 7 minutes ago IGEL Brings Now & Next Workspace & Endpoint Security Summits to Five European Cities
Published on 05/27/2026 at 19:10, 3 hours 53 minutes ago 124th Annual General Meeting of Romande Energie Holding SA
Published on 05/27/2026 at 23:00, 3 minutes ago BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
Published on 05/27/2026 at 20:28, 2 hours 34 minutes ago Combined Shareholders’ Meeting of May 27, 2026
Published on 05/27/2026 at 17:45, 5 hours 18 minutes ago Imerys-05-2026-information-share-capital-and-voting-rights-as-of-30-April-2026
Published on 05/27/2026 at 17:45, 5 hours 18 minutes ago Description of Share buyback program - May 2026
Published on 05/27/2026 at 17:45, 5 hours 18 minutes ago Report on share repurchases from 20 to 26 May 2026
